Mar 20 |
Earnings Scheduled For March 20, 2024
|
Mar 13 |
Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024
|
Feb 29 |
private equity firms who own 35% along with institutions invested in Trevi Therapeutics, Inc. (NASDAQ:TRVI) saw increase in their holdings value last week
|
Feb 28 |
Trevi Therapeutics to Participate in Upcoming March Events
|
Feb 6 |
Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Jan 19 |
We're Not Very Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Rate
|
Jan 17 |
Trevi Therapeutics, Inc. (TRVI) Upgraded to Strong Buy: Here's Why
|
Jan 4 |
Trevi Therapeutics Provides Business Updates
|
Dec 5 |
Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)
|
Nov 30 |
Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)
|